The present invention provides compounds of Formula A: or a pharmaceutically acceptable<；br />； sait, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The<；br />； present invention further provides pharmaceutical compositions comprising such<；br />； compounds and methods of using such compounds for treating, preventing, inhibiting,<；br />； ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a<；br />； parasite, such as leishmaniasis, human African trypanosomiasis and Chagas disease.
